Open access · OA
via Europe PMC
From cell to disease: Regulatory networks and mechanisms of super‑enhancers in aging (Review).
Wang X, Deng W, Tu S, Tang H, Yin K, Zhu X.
Molecular medicine reports · 2026
Abstract
Aging is accompanied by a gradual loss of cellular function and systemic weakening of the homeostasis of multiple tissues, leading to a variety of age‑related diseases and eventual mortality. Super‑enhancers are a distinct class of cis‑regulatory elements with strong transcriptional activation properties; they are bound by a large number of key transcription factors and cofactors, and possess distinct characteristic modification marks of enhancers. The past decade has seen an exponential growth in the field of super‑enhancer research, partly because of the strong transcriptional activity of super‑enhancers. Super‑enhancers are notably activated in response to aging or aging‑related factors, and serve a pivotal role in aging and aging‑related diseases by modulating key biological processes, including cell proliferation, differentiation and senescence(definition). In the present review, the changes in super‑enhancers under aging‑related stimuli are initially discussed. The mechanistic contributions of super‑enhancers to cellular senescence from the perspective of DNA damage and mitochondrial dysfunction(definition), two telomere(definition) attrition, cellular senescence)." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">hallmarks of aging(definition), are then systematically summarized. Furthermore, the pathogenic involvement of super‑enhancer dysregulation in specific age‑related disorders, including atherosclerosis and type Ⅱ diabetes, is explored, highlighting the potential of super‑enhancers as therapeutic targets. Finally, the current challenges and prospects of super‑enhancers within the context of aging biology are discussed, aiming to provide novel theoretical guidance for the treatment of age‑associated diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3892/mmr.2026.13964
- Canonical
- link ↗
- Fetched
- 2026-10-06 MST
Cite this
APA
X, W., W, D., S, T., H, T., K, Y., & X., Z. (2026). From cell to disease: Regulatory networks and mechanisms of super‑enhancers in aging (Review). <em>Molecular medicine reports</em>. https://doi.org/10.3892/mmr.2026.13964
Vancouver
X W, W D, S T, H T, K Y, X. Z. From cell to disease: Regulatory networks and mechanisms of super‑enhancers in aging (Review). Molecular medicine reports. 2026. doi:10.3892/mmr.2026.13964.
BibTeX
@article{wang2026Fromce,
title = {From cell to disease: Regulatory networks and mechanisms of super‑enhancers in aging (Review).},
author = {Wang X and Deng W and Tu S and Tang H and Yin K and Zhu X.},
journal = {Molecular medicine reports},
year = {2026},
doi = {10.3892/mmr.2026.13964},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
RenJi Hospital 2020
Open access · US-GOV
Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)
Signal Transduction and Targeted Therapy 2022
Open access · CC-BY
Nanoparticles in the diagnosis and treatment of vascular aging and related diseases
Cells 2022
Open access · CC-BY
Cellular Senescence in Aging Lungs and Diseases
Bio Systems 2026
Citation only
Loss of thermodynamic efficiency of various organs and functions of Drosophila melanogaster during aging.
Endocrinology 2021
Open access · OA
Role of Cellular Senescence in Type II Diabetes
International Journal of Molecular Sciences 2023
Open access · CC-BY